ACB.TO - Aurora Cannabis Inc.

Toronto - Toronto Delayed Price. Currency in CAD
7.00
+0.01 (+0.14%)
At close: 3:56PM EDT
Stock chart is not supported by your current browser
Previous Close6.99
Open6.96
Bid6.98 x 0
Ask7.01 x 0
Day's Range6.90 - 7.19
52 Week Range6.21 - 16.24
Volume4,023,884
Avg. Volume4,130,856
Market Cap7.106B
Beta (3Y Monthly)2.76
PE Ratio (TTM)N/A
EPS (TTM)-0.29
Earnings DateNov 11, 2019 - Nov 15, 2019
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est10.72
  • Why You Should Buy This Stock on Analyst Downgrades
    The Motley Fool

    Why You Should Buy This Stock on Analyst Downgrades

    Sometimes, an analyst downgrade is actually a buying opportunity in disguise like the recent sell rating of Aurora Cannabis (TSX:ACB)(NYSE:ACB).

  • 1 Cannabis Stock Is All You Need to Get Wealthy
    The Motley Fool

    1 Cannabis Stock Is All You Need to Get Wealthy

    You shouldn’t be frustrated with how the cannabis industry is behaving in the present. Things are beginning to settle down. If you want to get wealthy, pick Aurora Cannabis Inc. (TSX:ACB)(NYSE:ACB).

  • Canopy Growth Looks for CEO, Linton Gets a New Role
    Market Realist

    Canopy Growth Looks for CEO, Linton Gets a New Role

    Canopy Growth took the market by surprise and let CEO Bruce Linton go. After leaving Canopy Growth, Linton joined three companies in an advisory role.

  • CannTrust Loses License: Will It Fall below $1?
    Market Realist

    CannTrust Loses License: Will It Fall below $1?

    CannTrust reported that its license under the Cannabis Act was suspended. The company won't be able to produce cannabis. Will CannTrust fall below $1?.

  • Cannabis Roundup: IIPR, WEED, ACB, and APHA
    Market Realist

    Cannabis Roundup: IIPR, WEED, ACB, and APHA

    The markets were flat today as the Fed started its two-day meeting. Cannabis ETFs reported mixed performance, and cannabis stocks traded mostly in the red.

  • The Canadian Press

    Most actively traded companies on the TSX

    TORONTO — Some of the most active companies traded Tuesday on the Toronto Stock Exchange:Toronto Stock Exchange (16,834.75, up 83.44 points.)Encana Corp. (TSX:ECA). Energy. Down 48 cents, or 6.53 per cent, to $6.87 on 15.8 million shares.Baytex Energy Corp. (TSX:BTE). Energy. Down four cents, or 1.78 per cent, to $2.21 on 13 million shares.Crescent Point Energy Corp. (TSX:CPG). Energy. Down 22 cents, or 3.51 per cent, to $6.05 on 8.4 million shares.Aurora Cannabis Inc. (TSX:ACB). Health care. Down 27 cents, or 3.72 per cent, to $6.99 on 8.1 million shares.Canadian Natural Resources Ltd. (TSX:CNQ). Energy. Down $1.12, or 2.95 per cent, to $36.85 on 8 million shares.Kinross Gold Corp. (TSX:K). Materials. Up 35 cents, or 5.38 per cent, to $6.86 on 5.8 million shares.Companies in the news:CannTrust Holdings Inc. (TSX:TRST). Down 29 cents or 14.6 per cent to $1.70. CannTrust Holdings Inc. says it received a notice of licence suspension from Health Canada, which has been investigating the cannabis company for allegedly cultivating pot in unlicensed rooms. The Vaughan, Ont.-based company says Health Canada has suspended its authority to sell cannabis or to produce cannabis, other than cultivating and harvesting.Magna International. (TSX:MG). Unchanged at $71.32. Canadian manufacturers say they are keeping a close eye on the strike at General Motors in the U.S. as workers picket for a second day. More than 48,000 unionized workers in the U.S. walked off the job Monday over issues such as wages, health care and job security in the first strike at the U.S. manufacturer in more than a decade. Magna International spokesman Scott Worden said in a statement that the auto parts maker was in a "wait-and-see" mode and declined to outline impacts so far.Canopy Growth Corp. (TSX:WEED). Up 59 cents or 1.6 per cent to $37.50. Canopy Growth Corp. expects to complete its search for a new chief executive officer by the end of the calendar year, its chairman said Tuesday during its first annual meeting without co-founder Bruce Linton at the helm. Chairman John Bell commended Linton on his hefty contributions to the Smiths Falls, Ont.-based cannabis producer. Meanwhile, Linton also on Tuesday, announced his next moves will include advisory roles including at U.S.-based dispensary company Gage Cannabis Co. and Toronto-based Mind Medicine Inc., which is focused on psychedelic-based medicines.Imperial Oil Ltd. (TSX:IMO). Up 26 cents to $36.57. Imperial Oil Ltd. announced Tuesday that chairman and chief executive Rich Kruger will step down after leading the Calgary-based company, which is about 70 per cent owned by Texas-based Exxon Mobil Corp., since 2013. In his role, Kruger complained publicly often about red tape, focusing in recent years on how long it took to win Alberta regulatory approval for the two-phase, 150,000-barrel-per-day Aspen thermal oilsands project, first proposed in 2013. Analysts said they expect little change in direction under Brad Corson, a 36-year Exxon employee who becomes president immediately and becomes chairman and CEO on Jan. 1.Shopify Inc. (TSX:SHOP).Down $11.81 or 2.6 per cent to $435.67. Shopify Inc. says its e-commerce and retail platform has been given new features to help U.S. merchants sell hemp and hemp-derived cannabidiol products where permitted by law. The announcement follows last year's passage of U.S. federal legislation that removed hemp from the Controlled Substances Act, which still covers cannabis products. Hemp may contain CBD, a compound with potential medicinal qualities, but without significant levels of THC — a compound in cannabis that produces a high. Shopify says the new features will help its clients tap into a growing regulated industry in the U.S. by providing tools for marketing, payments and shipping products. The Canadian Press

  • Aurora versus Canopy: A Post-Earnings Valuation Update
    Market Realist

    Aurora versus Canopy: A Post-Earnings Valuation Update

    On September 16, Aurora Cannabis was trading at 7.26 Canadian dollars. Its stock has fallen 14.7% since it reported its fiscal 2019 fourth-quarter results.

  • Baystreet

    Psychedelic Drug Treatments Are Just Beginning to Capture Sizable Investor Interest

    Psychedelic substances are gaining traction as a treatment for mental illnesses, creating sizable opportunities ...

  • Cannabis Roundup: MMEN, ACB, WEED, and CTST
    Market Realist

    Cannabis Roundup: MMEN, ACB, WEED, and CTST

    Today at 2:10 PM ET, the S&P; 500 Index fell 0.3% as investors watched rising oil prices. The cannabis sector also fell today, as its ETFs traded in the red.

  • Aurora Cannabis Focuses on the US CBD Market
    Market Realist

    Aurora Cannabis Focuses on the US CBD Market

    On September 12, Aurora Cannabis (ACB) Chair Michael Singer spoke with CNN Business. He said, “We expect to have a significant footprint in the US in the coming quarters." The company also highlighted its “laser-focused” stance on the hemp-derived CBD (cannabidiol) market in the US on its fourth-quarter earnings call. BDS Analytics and Arcview Market […]

  • Cannabis Legalization: New Jersey Continues to Wait
    Market Realist

    Cannabis Legalization: New Jersey Continues to Wait

    On September 12, the New Jersey Senate was set to vote on the expungement bill for cannabis convicts. However, new legislation was introduced.

  • Marijuana Investors: Why Aurora Cannabis (TSX:ACB) May Actually Be the Cheapest Stock on the TSX Index
    The Motley Fool

    Marijuana Investors: Why Aurora Cannabis (TSX:ACB) May Actually Be the Cheapest Stock on the TSX Index

    After a "weak" fourth quarter, Aurora Cannabis Inc. (TSX:ACB)(NYSE:ACB) looks like a play that could make investors rich come 2020 and beyond.

  • Aurora Cannabis: Analysts’ Target Price after Its Earnings
    Market Realist

    Aurora Cannabis: Analysts’ Target Price after Its Earnings

    Aurora Cannabis (ACB) reported its fourth-quarter results on September 11. The results disappointed analysts and investors.

  • 3 All-Too-Common Investing Mistakes
    The Motley Fool

    3 All-Too-Common Investing Mistakes

    There are a lot of mistakes investors could be making, but these three are super common.

  • Aurora Cannabis (TSX:ACB): Why You Should Buy the After-Earnings Dip
    The Motley Fool

    Aurora Cannabis (TSX:ACB): Why You Should Buy the After-Earnings Dip

    Despite failing to deliver results on par with analysts estimates, here is why Aurora Cannabis Inc. (TSX:ACB)(NYSE:ACB) is still an interesting option.

  • Better Buy: Lightspeed (TSX:LSPD) vs. Aurora Cannabis (TSX:ACB)
    The Motley Fool

    Better Buy: Lightspeed (TSX:LSPD) vs. Aurora Cannabis (TSX:ACB)

    Are you better off buying cannabis stocks like Aurora Cannabis Inc (TSX:ACB)(NYSE:ACB) or tech startups like Lightspeed POS Inc (TSX:LSPD)?

  • Forget Aurora Cannabis (TSX:ACB): Buy This Marijuana Stock Instead
    The Motley Fool

    Forget Aurora Cannabis (TSX:ACB): Buy This Marijuana Stock Instead

    Here is why Green Thumb Industries Inc (CNSX:GTII) is an excellent cannabis stock to consider buying.

  • Millennials: Can Cannabis Stocks Still Make You a Millionaire?
    The Motley Fool

    Millennials: Can Cannabis Stocks Still Make You a Millionaire?

    The cannabis sector is not the instant money maker it once was for investors, but stocks like Canopy Growth Corp (TSX:WEED)(NYSE:CGC) can still offer value.

  • Cannabis Coverage by Cowen: Cresco, Curaleaf, Acreage
    Market Realist

    Cannabis Coverage by Cowen: Cresco, Curaleaf, Acreage

    Despite Aurora Cannabis's subdued results, Cowen initiated coverage on five cannabis stocks: CRLBF, GTBIF, CURLF, MMNFF, and ACRGF.

  • Cannabis Roundup: IIPR, ACB, and WEED
    Market Realist

    Cannabis Roundup: IIPR, ACB, and WEED

    Cannabis ETFs, which fell yesterday, showed some recovery today. Also, the majority of the cannabis stocks were trading in the green.

  • Aurora Cannabis says it's 'killing it' in Canada, so why aren't analysts excited?
    Yahoo Finance Canada

    Aurora Cannabis says it's 'killing it' in Canada, so why aren't analysts excited?

    Aurora Cannabis just booked the biggest cannabis revenues in the industry, but analysts are paring back expectations as the company warns of “volatile” quarterly revenues and a sales “plateau” into the end of the calendar year.